214 related articles for article (PubMed ID: 20729102)
21. [Three cases of Pseudomyxoma peritonei treated with intraperitoneal inoculation of cisplatin through an implantable port system].
Suzuki T; Umekita N; Inoue S; Miyamoto S; Maeshiro T; Awane Y
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1449-51. PubMed ID: 9703851
[TBL] [Abstract][Full Text] [Related]
22. Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.
Butterworth SA; Panton ON; Klaassen DJ; Shah AM; McGregor GI
Am J Surg; 2002 May; 183(5):529-32. PubMed ID: 12034386
[TBL] [Abstract][Full Text] [Related]
23. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.
Andréasson H; Graf W; Nygren P; Glimelius B; Mahteme H
Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859
[TBL] [Abstract][Full Text] [Related]
24. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy].
Elias D; Laurent S; Antoun S; Duvillard P; Ducreux M; Pocard M; Lasser P
Gastroenterol Clin Biol; 2003 Apr; 27(4):407-12. PubMed ID: 12759682
[TBL] [Abstract][Full Text] [Related]
25. [Pseudomyxoma peritonei: new concept and new therapeutic approach].
Loungnarath R; Causeret S; Brigand C; Gilly FN; Glehen O
Ann Chir; 2005 Feb; 130(2):63-9. PubMed ID: 15737316
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
27. Survival of patients with pseudomyxoma peritonei treated by serial debulking.
Järvinen P; Järvinen HJ; Lepistö A
Colorectal Dis; 2010 Sep; 12(9):868-72. PubMed ID: 19519686
[TBL] [Abstract][Full Text] [Related]
28. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival.
Huang HC; Huang YS; Shyr YM; Yen SH; Chang FY; Lee SD
Hepatogastroenterology; 2002; 49(46):999-1001. PubMed ID: 12143263
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of pseudomyxoma peritonei is developing].
Lepistö A; Osterlund P; Järvinen HJ
Duodecim; 2010; 126(14):1693-9. PubMed ID: 20804088
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei: need to establish a multi-institutional registry.
Yan TD
Ann Surg; 2008 Mar; 247(3):556-7. PubMed ID: 18376211
[No Abstract] [Full Text] [Related]
32. Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL
Am J Surg; 2011 Feb; 201(2):149-56. PubMed ID: 20832051
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
Güner Z; Schmidt U; Dahlke MH; Schlitt HJ; Klempnauer J; Piso P
Int J Colorectal Dis; 2005 Mar; 20(2):155-60. PubMed ID: 15503065
[TBL] [Abstract][Full Text] [Related]
34. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Hosch WP; Rudi J; Stremmel W
Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
[TBL] [Abstract][Full Text] [Related]
35. [Case report - cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei complicated with long-term persisting intestinal pneumonitis].
Kawashima M; Kitai T
Gan To Kagaku Ryoho; 2012 May; 39(5):801-3. PubMed ID: 22584335
[TBL] [Abstract][Full Text] [Related]
36. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg Oncol; 2007 Feb; 14(2):493-9. PubMed ID: 17103067
[TBL] [Abstract][Full Text] [Related]
37. [Pseudomyxoma peritonei--a syndrome with varying prognosis].
Mahteme H; Graf W
Lakartidningen; 2003 Sep; 100(38):2936-40. PubMed ID: 14558213
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results.
Elias DM; Ouellet JF
Surg Oncol Clin N Am; 2001 Oct; 10(4):915-33, xi. PubMed ID: 11641098
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve.
Andréasson H; Lorant T; Påhlman L; Graf W; Mahteme H
Eur J Surg Oncol; 2014 Aug; 40(8):930-6. PubMed ID: 24656455
[TBL] [Abstract][Full Text] [Related]
40. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
Hsu KH; Chou CY; Chang YC
Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
